Enhanced central chemoreception contributes to breathing problems in hypertension
Active Project Grant Awarded Last action
- Award ID
- F31HL172642
- Recipient
-
University Of Connecticut UEI WNTPS995QBM7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $146,703
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 51% complete
- Place of performance
- Storrs, CT 06269, USA
Award details come from USAspending.gov.
Description
- Abstract
- Central chemoreception is the mechanism by which the brain regulates breathing in response to changes in blood CO2/h+. The retrotrapezoid nucleus (RTN) is an important site for central respiratory chemoreception, and there is evidence suggesting RTN chemoreception is hyper-active in spontaneously hypertensive rats (shrs) and this contributes to unstable periodic breathing. This is significant because breathing abnormalities can lead to enhanced sympathetic outflow, which further exacerbates the progression of hypertension. Despite this significance, the cellular and molecular basis for disordered breathing in hypertension is unclear. My central hypothesis is that over-activation of RTN chemoreception contributes to disordered breathing in hypertension, and treatments that limit RTN chemoreception will improve cardiorespiratory function in shrs. To test this, i will: use a combination of electrophysiology and imaging approaches to characterize the CO2/h+ response of RTN neurons, astrocytes, and arterioles in slices from shrs and control rats (aim 1) and determine whether key elements of RTN chemoreception can be targeted to improve breathing and blood pressure in shrs (aim 2). Important outcomes of this work include 1) determining the cellular and molecular basis of RTN dysfunction in shrs, 2) identifying candidate therapeutic targets for the treatment of unstable breathing in hypertension, and 3) providing valuable training in the molecular, cellular, and whole-animal approaches which will poise me to achieve my goal of becoming an independent investigator.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $49,277 | |
| Amendment | $48,713 | |
| Amendment | $0 | |
| Original award | $48,713 |
Quick answers
Who received award F31HL172642?
F31HL172642 was awarded to University Of Connecticut by National Heart Lung and Blood Institute (National Institutes of Health) on December 26, 2024.
How much is award F31HL172642 worth?
$146,703 has been obligated on F31HL172642.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award